FDA approves 3 pacemaker devices

Candace Stuart | March 25, 2014 | Cardiovascular Business | Heart Failure

The FDA approved three St. Jude Medical pacemaker devices, including its quadripolar cardiac resynchronization therapy pacemaker, St. Jude announced today.

The FDA’s approval paves the way for the commercial launch of the Allure Quadra Cardiac Resynchronization Therapy Pacemaker, the Assurity pacemaker and the Endurity pacemaker family of devices. St. Jude Medical reported that the Allure approval marks the first time the quadripolar technology has become available in the U.S.

The Allure’s quadripolar technology is designed to widen physicians’ options in patient care and facilitate additional pacing configurations while providing diagnostic monitoring capabilities. The Assurity and Endurity devices are smaller profile technologies available in dual and single chamber formats.

St. Paul, Minn.-based St. Jude Medical said it planned to launch the three devices by the end of the first quarter of this year.

Candace Stuart, Contributor

Around the web

Health Imaging

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

FDA approves 3 pacemaker devices

Related Content

Around the web